Abstract

Panax ginseng roots have long been used as a medicinal herb in oriental countries. We have investigated anti-proliferative effects of lipid soluble Panax ginseng components on human renal cancer cell lines. Petroleum ether extract of Panax ginseng roots (GX-PE) or its partially purified preparation (7:3 GX) was added to cultures of three human renal cell carcinoma (RCC) cell lines, A498, Caki-1, and CURC II. Proliferation of RCC cells was estimated by a [3H]thymidine incorporation assay and cell cycle distribution was analyzed by flow cytometry. GX-PE, 7:3 GX, panaxydol and panaxynol inhibited proliferation of all three RCC cell lines in a dose dependent manner in vitro with an order of potency, 7:3 GX > panaxydol > panaxynol = GX-PE. Additive effect of interleukin 4 was also demonstrated, most prominently in Caki-1 which responded poorly to GX-PE alone. Analysis of cell cycle in CURC II and Caki-1 treated with GX-PE demonstrated increase in G1 phase population and corresponding decrease in S phase population. The present study demonstrated that proliferation of human RCC cell lines were inhibited by lipid soluble components of Panax ginseng roots by blocking cell cycle progression at G1 to S phase transition.

Highlights

  • Panaxynol and panaxydol corresponded to fractions 3 and 4 of GX-PE, respectively

  • GX-PE completely inhibited growth of A498 and CURC II at 80 μg/ml and the growth of Caki-1 was inhibited by over 60% at 100 μg/ml. These results show that lipid soluble components of Panax ginseng roots inhibit proliferation of human renal cell carcinoma (RCC) cell lines directly and growth of transformed cells is preferentially inhibited especially at a high concentration of GX-PE

  • We demonstrated that lipid-soluble components from Panax ginseng roots inhibit proliferation of human RCC cell lines in vitro and that the growth inhibition accompanies a block in cell cycle progression at G1 phase

Read more

Summary

Introduction

The most extensively studied component of Panax ginseng for its activity is a glycoside, saponin (Brekman and Dardymov, 1969). Others such as phenolic acids, alkaloids and lignans may be responsible for many of the important effects of Panax ginseng. In an effort to develop a new therapeutic agent for RCC, we have tested whether lipid soluble components of Panax ginseng inhibit growth of RCC cell lines in vitro and investigated the mechanism of anti-proliferative effects by analyzing cell distribution at different stages of a cell cycle. Combination of lipid soluble components of Panax ginseng and interleukin 4 as a possible anticancer drug for metastatic RCC has been investigated

Materials and Methods
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.